|
|
|
Insider
Information: |
Daly James M |
Relationship: |
Director |
City: |
Wilmington |
State: |
DE |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
159,749 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,952,494 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
159,749 |
|
|
Total
Value |
$1,952,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
37.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
EVP, Chief Commercial ... |
2015-06-23 |
3,521 |
2014-02-13 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2023-08-14 |
20,503 |
2016-05-04 |
0 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-05-29 |
24,654 |
2019-09-09 |
0 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
109,873 |
2022-01-04 |
0 |
Premium* |
|
Madrigal Pharmaceuticals Inc |
MDGL |
Director |
2024-04-02 |
1,198 |
2024-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,022 |
3,521 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2016-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,202 |
20,202 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
34,337 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2018-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,363 |
44,700 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
56,873 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
65,702 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
26,232 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2021-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,059 |
3,059 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2022-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,377 |
14,377 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2022-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,391 |
9,450 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,082 |
49,459 |
0 |
- |
|
BLCM |
Bellicum Pharmaceuticals,... |
Director |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,414 |
109,873 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
|
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
40,503 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,552 |
18,002 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
|
|
2024-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,652 |
24,654 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2015-02-23 |
4 |
OE |
$18.32 |
$50,893 |
D/D |
2,778 |
6,299 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2015-02-24 |
4 |
OE |
$16.62 |
$138,511 |
D/D |
8,334 |
11,855 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2015-01-23 |
4 |
OE |
$16.62 |
$189,352 |
D/D |
11,109 |
14,630 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-06-23 |
4 |
OE |
$16.62 |
$189,386 |
D/D |
11,111 |
8,334 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-09-23 |
4 |
OE |
$16.62 |
$189,386 |
D/D |
11,111 |
11,111 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-05-23 |
4 |
OE |
$16.62 |
$189,387 |
D/D |
11,111 |
11,111 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-07-23 |
4 |
OE |
$16.62 |
$189,387 |
D/D |
11,111 |
11,111 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-08-25 |
4 |
OE |
$16.62 |
$189,387 |
D/D |
11,111 |
11,111 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-10-23 |
4 |
OE |
$16.62 |
$189,387 |
D/D |
11,111 |
11,111 |
0 |
- |
|
INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
|
2014-11-24 |
4 |
OE |
$16.62 |
$189,387 |
D/D |
11,111 |
11,111 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|